ArticleOncoTargets and therapy2022

Erratum: A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.